Select Page

Media & Analysis

News

Contact person

David Munis Zepernick

David Munis Zepernick

Director, Member Engagement and Communication

dz@mva.org

+45 2498 1668

Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.

MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.

If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.

Canadian health and hospital innovation expert, Fabrice Brunet, confirmed as keynote speaker at MVA Annual Summit 2024

We are happy to inform you, that we have managed to "recruit" Fabrice Brunet and convinced him to cross the Atlantic to deliver a keynote presentation on healthcare and hospital innovation titled "The role of innovation in transforming healthcare" at this year´s MVA Annual Summit 11th of November in Copenhagen Fabrice Brunet is director general of the Health Innovation District of Montréal and former director general of Centre hospitalier de l'Université de Montréal (CHUM). As such Fabrice...

Apply for BioInnovations Institute’s Venture Lab program – deadline 28th of August!

The Venture Lab program starts with an intense, three-day bootcamp starting with a pitch in front of the whole building and followed by focused workshops to kickstart your start-up development, team-building, and scientific maturation. In 12 months, the Venture Lab program covers launching a business comprehensively. You'll delve into customer insights, competitor analysis, regulatory navigation, fundraising strategies, operational scaling, partnership dynamics, and exit planning....

Welcome to the 13th annual edition of The Future of Swedish & Danish Life Science!

This annual international press-monitored congress features a highly relevant seminar lineup that emphasize the most current developments, collaborations, challenges and opportunities for the Swedish and Danish life science sectors, pre-bookable one-to-one partnering sessions, exceptional networking prospects, and a vibrant exhibition showcasing the offerings of many prominent industry stakeholders. These fundamental components run in parallel, ensuring attendees immerse in a dynamic, full-day...

Register for Nordic Life Science Days with your 20 % MVA member discount

Nordic Life Science Days 2024 will return to Malmö, Sweden on 18-19 September at Malmömässan located Måsgatan 6, 215 32 Malmö. Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world of life science, and created a unique place to do business. Most attendees express their delight in the informal atmosphere, combined with an organised approach to meeting...

Danish-Swedish collaboration paves the way for new treatment of type-1 diabetes

Is the English headline of the article published last week in Swedish Daily, Dagens Nyheter, highlighting yet another piece of MVA managed Swedish-Danish collaboration, the Type 1 Diabetes screening project called DiaUnion, which involved a handful of distinguished partners including Interreg Öresund-Kattegat-Skagerrak, which funds the project, and Region Skåne and Lund University and on the Danish side Region Hovedstaden and Steno Diabetes Center Copenhagen.

“Life Science in the Medicon Valley cluster is the the goose that lays the golden egg”, opinion piece By MVA CEO Anette Steenberg

Life Science in the Medicon Valley cluster is the the goose that lays the golden egg, is the headline in the opinion piece by MVA CEO Anette Steenberg published Sunday in Danish Daily Berlingske. We think it´s a must-read for life science decision-makers in Denmark, and although it is in Danish, we hope some Swedish life science decision-makers will read it too.

“We must win the battle for talent!” Business column in Nordic Life Science Magazine by MVA chairman, Niels Abel Bonde

In the old days, the major pharmaceutical companies and successful life science companies were generally in the driving seat and could pick and choose from qualified candidates. But times have changed and to recruit the new generations we need a more holistic approach. Denmark and Sweden are generally well positioned in the new global battle for talent, but the battle is intensifying, and we cannot rest on our laurels. Hopefully the forthcoming updated national life science strategies of both...

2 CUREX appoints Ole Thastrup as new CEO, aborts delisting and announces directed share issue to a private investment company

MVA member 2cureX AB (publ), a company pioneering the use of 3D tumoroids for drug sensitivity prediction in cancer patients, is pleased to announce the appointment of its Founder, Ole Thastrup, as the new CEO. Tonni Bülow-Nielsen, Chairman of the Board, expressed his enthusiasm, stating: “We are delighted to have Ole assume the CEO role during this pivotal phase in 2cureX’s development. Additionally, I extend my gratitude to our CFO Kenneth G. Johansen for taking the responsibility as Acting...

MVA congratulates professor Hindrik Mulder and Lund University with the prestigious Novo Nordisk Foundation Lecture Prize

Professor Hindrik Mulder’s research on islet cells and his commitment to the scientific community have been recognized as he receives the 2024 Novo Nordisk Foundation Lecture Prize, which comes with a DKK 600,000 award. “Swedish-Danish Medicon Valley Alliance would like to congratulate both professor Hindrik Mulder and Lund University with the prestigious award. It testifies to both the high quality of Medicon Valley based life science research, the growing awareness of the synergies between...

Key Considerations for Healthcare Companies Listing on a US Exchange – Podcast episode from MVA member DNB//Back Bay

Healthcare companies considering listing on a US exchange have several important decisions and steps ahead of them. In the latest episode of the capital markets podcast series, DNB//Back Bay is privileged to sit down with the co-head of the global life science practice at Cooley to share best practices on the key mechanics of a US listing, including practical steps for preparation, how to build an IPO-ready team, preparing and submitting key documents, and the most common mistakes companies...